These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Acoustic impairment is a distinguishable clinical feature of Asidan/SCA36. Ikeda Y; Ohta Y; Kurata T; Shiro Y; Takao Y; Abe K J Neurol Sci; 2013 Jan; 324(1-2):109-12. PubMed ID: 23140984 [TBL] [Abstract][Full Text] [Related]
13. Assessment of swallowing in motor neuron disease and Asidan/SCA36 patients with new methods. Morimoto N; Yamashita T; Sato K; Kurata T; Ikeda Y; Kusuhara T; Murata N; Abe K J Neurol Sci; 2013 Jan; 324(1-2):149-55. PubMed ID: 23146615 [TBL] [Abstract][Full Text] [Related]
14. The p62 antibody reveals various cytoplasmic protein aggregates in spinocerebellar ataxia type 6. Seidel K; Brunt ER; de Vos RA; Dijk F; van der Want HJ; Rüb U; den Dunnen WF Clin Neuropathol; 2009; 28(5):344-9. PubMed ID: 19788049 [TBL] [Abstract][Full Text] [Related]
15. [Recent advances in clinical and genetic research of spinocerebellar ataxia type 36]. Zeng S; Tang B; Wang J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):886-9. PubMed ID: 26663071 [TBL] [Abstract][Full Text] [Related]
16. An autopsy case of an aged patient with spinocerebellar ataxia type 2. Ishida C; Komai K; Yonezawa K; Sakajiri K; Nitta E; Kawashima A; Yamada M Neuropathology; 2011 Oct; 31(5):510-8. PubMed ID: 21134000 [TBL] [Abstract][Full Text] [Related]
17. Repeat sizes of NOP56 gene in a Japanese Asidan (SCA36) family with clinical anticipation. Ohta Y; Ikegami K; Sato K; Hishikawa N; Omote Y; Takemoto M; Yamashita T; Abe K J Neurol Sci; 2020 Nov; 418():117150. PubMed ID: 32980141 [No Abstract] [Full Text] [Related]
18. Spinocerebellar ataxia type 4 (SCA4): Initial pathoanatomical study reveals widespread cerebellar and brainstem degeneration. Hellenbroich Y; Gierga K; Reusche E; Schwinger E; Deller T; de Vos RA; Zühlke C; Rüb U J Neural Transm (Vienna); 2006 Jul; 113(7):829-43. PubMed ID: 16362839 [TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31). Ishikawa K; Nagai Y Neurotherapeutics; 2019 Oct; 16(4):1106-1114. PubMed ID: 31755042 [TBL] [Abstract][Full Text] [Related]
20. NMR solution structures of d(GGCCTG) Yi J; Wan L; Liu Y; Lam SL; Chan HYE; Han D; Guo P Int J Biol Macromol; 2022 Mar; 201():607-615. PubMed ID: 35077744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]